Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ophthalmology, Macular Degeneration”

Showing 3 of 0 results

Large-scale testing (Phase 3)Study completedNCT01535261
What this trial is testing

Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Novartis Pharmaceuticals 357
Early research (Phase 1)Study completedNCT05262244
What this trial is testing

Targeted Fluorescence Imaging in AMD

Who this might be right for
Age-Related Macular DegenerationNAMD
University Medical Center Groningen 12
Not applicableStudy completedNCT01771081
What this trial is testing

Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy

Who this might be right for
OphthalmologyMacular EdemaMacular Degeneration
Bayer 911

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation